Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 51–100 of 1,297 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03104491	Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia	recruiting	Phase 1 / Phase 2	44	Leland MethenyOTHER	1	Sep 10, 2026	clinicaltrials
NCT04169737	Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	recruiting	Phase 2	168	M.D. Anderson Cancer CenterOTHER	1	Sep 10, 2026	clinicaltrials